52235

Cystourethroscopy, with fulguration (including cryosurgery or laser surgery) and/or resection of; MEDIUM bladder tumor(s) (2.0 to 5.0 cm)

CPT code 52235 describes a comprehensive and technically demanding urological procedure involving a cystourethroscopy paired with the surgical ablation or resection of medium-sized bladder tumors, defined explicitly as lesions measuring between 2.0 and 5.0 centimeters in diameter. This endoscopic intervention serves as both a diagnostic and therapeutic cornerstone in the management of urothelial malignancies, papillomas, and other focal bladder neoplasms. The procedure begins with the patient meticulously positioned in the dorsal lithotomy position. Following the induction of appropriate anesthesia, which is typically general or regional spinal anesthesia to eliminate the obturator reflex during lateral bladder wall resection, the perineum and external genitalia are prepped and draped in a sterile fashion. The urologic surgeon gently introduces a specialized endoscopic instrument, such as a cystoscope or resectoscope, through the urethral meatus. Under direct, illuminated visualization, the instrument is advanced along the urethra into the urinary bladder. Sterile irrigation fluid is continuously instilled to expand the bladder vault, allowing for an unobstructed, high-definition view of the entire internal mucosal lining. The surgeon systematically evaluates the anterior, posterior, lateral, and dome surfaces of the bladder, as well as the trigone, bladder neck, and ureteral orifices. Upon identifying the medium-sized tumor or tumors, careful measurements are taken to confirm the size falls within the 2.0 to 5.0 centimeter threshold. Utilizing advanced energy modalities delivered through the scope, such as an electrocautery cutting loop, laser fiber, or cryosurgical probe, the surgeon methodically resects or fulgurates the neoplastic tissue. It is critical that the resection extends sufficiently deep into the underlying detrusor muscle (muscularis propria) to secure a high-quality tissue specimen. This deep margin is vital for the pathologist to accurately stage the tumor and determine whether the cancer is muscle-invasive or non-muscle-invasive. Throughout the resection, precise hemostasis is maintained by selectively fulgurating bleeding vessels within the resection crater. Once the tumor is completely eradicated or resected, the resulting tissue chips and fragments are actively flushed out of the bladder using an evacuation device, such as an Ellik evacuator or Toomey syringe, and immediately preserved for histopathological analysis. The bladder is inspected one final time to verify complete tumor removal and absolute hemostasis. The cystourethroscope is then carefully withdrawn. A multi-lumen Foley catheter is frequently inserted at the conclusion of the surgery to facilitate continuous postoperative bladder drainage and, if necessary, continuous bladder irrigation to prevent clot retention. This meticulously executed procedure is paramount in mitigating the progression of bladder cancer, providing immediate symptomatic relief from tumor-induced hematuria, and yielding critical staging data necessary to guide subsequent oncological treatment pathways.

Clinical Indications

  • Presence of a previously identified medium-sized (2.0 to 5.0 cm) bladder mass or tumor noted on radiographic imaging such as CT urography or pelvic ultrasound.
  • Gross or microscopic hematuria necessitating cystoscopic evaluation that reveals a medium bladder tumor.
  • Recurrent urothelial carcinoma in a patient with a known history of bladder cancer presenting with a medium-sized lesion.
  • Unexplained lower urinary tract symptoms (LUTS) accompanied by positive urine cytology indicating a medium-sized neoplastic lesion.
  • Follow-up surveillance cystoscopy revealing new medium-sized tumor growth requiring immediate resection.

Procedure Steps

  1. The patient is placed in the dorsal lithotomy position, and the perineum and genitalia are prepped and draped in a standard sterile surgical fashion.
  2. Adequate anesthesia (typically general or spinal) is administered to ensure patient comfort and prevent reflex movement, particularly the obturator reflex.
  3. A well-lubricated cystourethroscope or resectoscope is gently advanced through the urethral meatus, down the urethra, and into the urinary bladder under direct visualization.
  4. The bladder is distended using a sterile irrigation fluid to allow for complete visualization of the bladder mucosa.
  5. A systematic diagnostic inspection of the entire bladder urothelium, bilateral ureteral orifices, bladder neck, and urethra is performed.
  6. The medium-sized bladder tumor(s), measuring between 2.0 and 5.0 cm, is identified, localized, and measured accurately.
  7. Using a resectoscope equipped with an electrocautery loop, or utilizing a laser/cryosurgery fiber, the tumor is methodically resected or fulgurated down to the deep muscle layer (muscularis propria).
  8. Hemostasis of the resection bed is meticulously achieved using electrocautery fulguration or laser coagulation.
  9. Resected tissue fragments are evacuated from the bladder using an Ellik evacuator, Toomey syringe, or continuous flow mechanism, and sent to pathology.
  10. The cystoscope is carefully withdrawn, and a Foley catheter is typically placed to provide continuous bladder drainage and optionally continuous bladder irrigation (CBI).

Coding Guidelines

  • Do not report CPT 52235 in conjunction with diagnostic cystourethroscopy (52000), as the diagnostic component is inherently included in the surgical procedure.
  • If multiple tumors of varying sizes are treated, code for the single largest tumor category. Do not aggregate the sizes of separate, distinct tumors to reach a larger code category.
  • When reporting multiple separate cystoscopic procedures performed during the same operative session, append modifier 51 to the secondary procedures, noting that NCCI edits may bundle certain codes.
  • If a biopsy (52204) is performed in a clearly distinct, separate area of the bladder from the tumor resection, it may be reported separately with modifier 59 or XU, provided documentation clearly supports separate sites.
  • This code explicitly applies to tumors measuring 2.0 to 5.0 cm. For minor tumors less than 2.0 cm, use 52224; for large tumors greater than 5.0 cm, use 52240.

Associated ICD-10 Codes